Central regions | Technology & innovation | Finance, business

Skolkovo and AstraZeneca launch medtech start-up acceleration

16 May '19
Russia’s Skolkovo Foundation and AstraZeneca, a global biopharmaceutical company, are putting together a new joint acceleration program for projects that develop solutions for cancer therapy, cardiovascular diseases, metabolism and kidney problems, and respiratory diseases, Firrma.ru reported.

Primer Capital, a Russian venture fund with international presence, is acting as partner for the acceleration initiative.

The program will be aimed at identifying promising ideas and solutions to benefit the above-mentioned medical fields and also at addressing a range of specific problems in the existing healthcare system. Developing and promoting digital medicine solutions is also a goal for this year’s acceleration program.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
26 May '20 | Technology & innovation
26 May '20 | Technology & innovation
26 May '20 | Finance, business | Technology & innovation
 

Feature stories

21 May '20
Russian and Italian researchers have developed a...
5 Apr '20
To extend the service life of medical fabric masks—an...
26 Feb '20
A Russian developer has come up with its own...
Search (News archive - 21991)

World of the Future, World of AI

Luc Jones: A Guide to Doing Business in Russia and the CIS Countries
Why Russians Don't Smile
Advertising
Venture_Russia_2019_eng
Advertising
NATT
Advertising
Marchmont News

Latest News

26 May '20
Sberbank, Russia’s largest savings bank, has bought...
25 May '20
Ecwid, a leading provider of social commerce...
22 May '20
The Russian Cabinet is mulling over possible...

Most read stories from last week

25 May '20
Ecwid, a leading provider of social commerce...
26 May '20
Sberbank, Russia’s largest savings bank, has bought...
26 May '20
Interview with Michael Pochepsky, a resident of the...